The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 ...

There is no association between COVID-19 vaccination in pregnancy and spontaneous abortion, according to a study published online.

The US FDA may limit Covid-19 boosters to high-risk groups only, citing lack of efficacy in healthy individuals. Meanwhile, ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to ...

The US Food and Drug Administration has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.

The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...

The national capital has reported 23 COVID-19 cases, prompting the Delhi government to issue an advisory asking all hospitals to prepare for the availability of beds, oxygen, medicines and vaccines.

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.